Clínica Las Condes S.A. informs the Commission for the Financial Market of Chile about the payment of dividends agreed at the Ordinary Shareholders' Meeting for an amount of Ch$1,214,092,891, with a payment deadline of 05/25/2023. Payment will be made through the Banco de Crédito e Inversiones by electronic voucher.
ESSENTIAL FACT: Clínica Las Condes S.A. informs the Chilean Financial Market Commission that at its Ordinary Shareholders' Meeting the report, balance sheet, financial statements and report of the external auditors for the year ended December 31, 2022, the distribution of profits of Ch$144.9515 per share, the remuneration of the Board of Directors, the appointment of external auditors and risk classifiers for the year 2023, among other agreements.
Clínica Las Condes S.A. convenes an Ordinary Shareholders' Meeting on April 25, 2023 at 10:00 a.m. at Estoril N° 450, Santiago. Topics such as the approval of the report, balance sheet, financial statements and report of external auditors, distribution of profits, fixing of remuneration of directors, appointment of external auditors and risk classifiers for the year 2023, among others, will be discussed. Shareholders will be able to participate and vote remotely.
Clínica Las Condes informs that the voluntary early redemption option for the Series E Bonds was accepted by bondholders, for an amount of 36,000 Development Units, equivalent to 72 Series E Bonds. Essential Fact No. 433.
Clínica Las Condes will offer a voluntary early redemption option to holders of Series E Bonds for a total amount of UF100,000 par value. The rescue will be carried out through Larraín Vial S.A. Corredora de Bolsa and will be carried out from December 26, 2022 until December 28, 2022. The value obtained will not accrue interest or readjustments and will be paid in its equivalent in pesos.
Clínica Las Condes informs that the voluntary early redemption option for the Series E Bonds was accepted by bondholders for an amount of 302,000 Development Units, equivalent to 604 Series E Bonds.
Clínica Las Condes S.A. will offer a voluntary early redemption option to holders of Series E Bonds for a total amount of UF402,000 par value. The rescue will take place on December 22, 2022 and is subject to certain conditions. Holders must communicate their acceptance by December 21, 2022.
Clínica Las Condes S.A. will offer voluntary early redemption option to holders of Series E Bonds for a total amount of 402,000 UF for outstanding capital, as provided in Article 130 of Law No. 18,045. The notice will be published on December 19, 2022 in the Diario el Líbero.
Clínica Las Condes informs the Chilean Financial Market Commission about a strategic alliance with Finis Terrae University, which does not commit the clinic's financial resources. The university will finance the investment in infrastructure and the clinic will provide an area of 4,000 m2 on loan for 10 years. The net book value of depreciation of the North Tower Green Building is MM$ 3,213. The clinic seeks to configure a powerful model of academy and the alliance involves attracting university...
ESSENTIAL FACT: Clínica Las Condes S.A. informs the Commission for the Financial Market of Chile that it has signed a Strategic Alliance Agreement with the Finis Terrae University to implement a comprehensive academic development project, including teaching, research and linkage with the environment, and transfer or create postgraduate programs in the Clinic from 2023. A loan was also agreed on dependencies of the Clinic for activities of the Faculty of Medicine of the University.
ESSENTIAL FACT: Clínica Las Condes S.A. informs the Chilean Financial Market Commission that it has concluded the collective bargaining process with the Company's Inter-Enterprise Union, reaching a full agreement and signing a collective bargaining agreement valid for three years.
Essential fact: Clínica Las Condes S.A. informs that in ordinary session, the Board of Directors appointed María Paz Pareja Ayala as manager of administration and finance of the Company, who occupied said position in an interim capacity. Registration in the Securities Registry No. 433.
Essential fact: Clínica Las Condes informs that its Board of Directors has appointed Ignacio Tapia Hortuvia as general manager of the Company in ordinary session. (140 characters)
ESSENTIAL FACT: Clínica Las Condes reports that a proration factor of 0.68493 was applied to the Series E Voluntary Early Redemption Option, because the number of bonds accepted exceeded the total amount offered. 196 Series E Bonds were redeemed for a total amount of 98,000 Development Units.
Clínica Las Condes S.A. will offer a voluntary early redemption option with its own resources to holders of Series E Bonds for a total amount of up to UF 50,000 for nominal value. The rescue will take place on July 22, 2022 and is subject to certain conditions. Holders must communicate their acceptance by July 21, 2022.
Key fact: Clínica Las Condes informs the Financial Market Commission that it has reached an agreement with Workers' Union No. 1, ending the collective bargaining process. The collective bargaining agreement shall be valid for three years.
Essential fact: Clínica Las Condes informs CMF Chile that, due to a fiber cut in the data centers of Entel, its internet service provider, the Company has been partially paralyzed. Emergency protocols have been activated to continue with the social march. (240 characters)
Las Condes Clinic informs the Commission for the Financial Market that Union No. 1 rejected its offer in the framework of collective bargaining, voting in favor of the strike. A mandatory mediation period will begin and the clinic has a contingency plan. Essential fact registered in the Securities Registry No. 433.
Essential fact: Clínica Las Condes reports partial interruption of its march due to failure in Entel's internet service. The situation was controlled with emergency protocols and normalization is expected today. Registration in the Securities Registry No. 433.
Clínica Las Condes reports that 198 Series E Bonds were redeemed for a total amount of 99,000 Development Units, after applying a proration factor of 0.553247, because the number of bonds whose redemption was accepted exceeded the total amount offered. Essential fact registered in the Securities Registry No. 433.
Clínica Las Condes S.A. offers a voluntary early redemption option to holders of Series E Bonds for a total amount of up to UF 106,500 par value. The rescue will take place on May 04, 2022 and is subject to certain conditions. Holders must communicate their acceptance by 3:00 p.m. on May 3, 2022.
Clínica Las Condes S.A. will offer voluntary early redemption option to holders of Series E Bonds for a total amount of up to 106,500 UF for outstanding capital, as provided in Article 130 of Law No. 18,045. The notice will be published in the Diario el Líbero and is attached to this communication.
Clínica Las Condes informs that the voluntary early redemption option of Series E Bonds was accepted by bondholders for an amount of 393,500 Development Units, equivalent to 787 Series E Bonds.
Essential fact: Clínica Las Condes reports change in administration. The General Manager, Jerónimo García Bacchiega, resigns and is replaced by Ignacio Tapia Hortuvia, who served as Administration and Finance Manager.
Clínica Las Condes will offer a voluntary early redemption option to holders of Series E Bonds for a total amount of up to UF400,000 par value. The rescue will take place on April 27, 2022 and is subject to certain conditions. Holders must communicate their acceptance before 14:00 hours of the same day. More details in the notice published in the newspaper El Líbero.
Clínica Las Condes S.A. informs the Financial Market Commission about the payment of dividends agreed at the Ordinary Shareholders' Meeting for an amount of Ch$5,525,021,174, with a payment deadline of 05/20/2022. Payment will be made through the Banco de Crédito e Inversiones by electronic voucher.
Clínica Las Condes informs the Chilean Financial Market Commission of the resolutions adopted at its Ordinary Shareholders' Meeting, including the approval of the distribution of profits in the amount of Ch$659.6366 per share, to be paid on May 20, 2022. Deloitte Auditores y Consultores Limitada was also appointed as external auditors for the financial year 2022.